MA30046B1 - Compose heterocyclique hybride - Google Patents

Compose heterocyclique hybride

Info

Publication number: MA30046B1
Authority: MA; Morocco
Prior art keywords: hybrid; heterocyclic compound; heterocyclic; compound; hybrid heterocyclic
Prior art date: 2005-12-02

Application number

MA31024A

Other languages

English (en)

Inventor

Tomoyasu Ishikawa

Kazuhiro Miwa

Masaki Seto

Hiroshi Banno

Youichi Kawakita

Original Assignee

Takeda Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-02

Filing date

2008-06-11

Publication date

2008-12-01

2008-06-11 Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical

2008-12-01 Publication of MA30046B1 publication Critical patent/MA30046B1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

MA31024A 2005-12-02 2008-06-11 Compose heterocyclique hybride MA30046B1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2005349858		2005-12-02
JP2006060648		2006-03-07

Publications (1)

Publication Number	Publication Date
MA30046B1 true MA30046B1 (fr)	2008-12-01

Family

ID=37897379

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA31024A MA30046B1 (fr)	2005-12-02	2008-06-11	Compose heterocyclique hybride

Country Status (15)

Country	Link
US (1)	US20100216788A1 (fr)
EP (1)	EP1957495A1 (fr)
JP (1)	JP2009517333A (fr)
KR (1)	KR20080084823A (fr)
AR (1)	AR057961A1 (fr)
AU (1)	AU2006319787A1 (fr)
BR (1)	BRPI0619911A2 (fr)
CA (1)	CA2631066A1 (fr)
CR (1)	CR10057A (fr)
MA (1)	MA30046B1 (fr)
NO (1)	NO20082870L (fr)
PE (1)	PE20071089A1 (fr)
RU (1)	RU2008126949A (fr)
TW (1)	TW200730527A (fr)
WO (1)	WO2007064045A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA06013996A (es) *	2004-06-02	2007-02-08	Takeda Pharmaceutical	Compuesto heterociclico fusionado.
JPWO2008072634A1 (ja) *	2006-12-12	2010-04-02	武田薬品工業株式会社	縮合複素環化合物
US7825127B2 (en)	2006-12-28	2010-11-02	Takeda Pharmaceutical Company, Limited	Method for treating cancer
EP2163258A1 (fr)	2007-06-19	2010-03-17	Takeda Pharmaceutical Company Limited	Médicament préventif/remède contre le cancer
TW200940546A (en) *	2008-03-03	2009-10-01	Takeda Pharmaceutical	Combination drug
TW200944528A (en) *	2008-03-12	2009-11-01	Takeda Pharmaceutical	Fused heterocyclic compound
WO2012177668A1 (fr)	2011-06-20	2012-12-27	E. I. Du Pont De Nemours And Company	Composés hétérocycliques utilisables en vue du traitement d'infections helminthiques
WO2013159095A1 (fr) *	2012-04-20	2013-10-24	Anderson Gaweco	Modulateurs de ror et leurs utilisations
MX367085B (es) *	2013-07-31	2019-08-05	Merck Patent Gmbh	Piridinas, pirimidinas y pirazinas como inhibidores de tirosina cinasa de bruton e inhibidores y usos de las mismas.
GB201520499D0 (en) *	2015-11-20	2016-01-06	Medical Res Council Technology	Compounds
IL306100A (en)	2021-04-13	2023-11-01	Nuvalent Inc	Amino-substituted heterocycles for the treatment of cancer with EGFR mutations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL112249A (en) *	1994-01-25	2001-11-25	Warner Lambert Co	Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
UA71945C2 (en) *	1999-01-27	2005-01-17	Pfizer Prod Inc	Substituted bicyclic derivatives being used as anticancer agents
MXPA06013996A (es) *	2004-06-02	2007-02-08	Takeda Pharmaceutical	Compuesto heterociclico fusionado.
MX2007001216A (es) *	2004-07-30	2007-03-23	Methylgene Inc	Inhibidores de la senalizacion del receptor del factor de crecimiento endotelial vascular y del receptor del factor de crecimiento del hepatocito.
TW200740820A (en) *	2005-07-05	2007-11-01	Takeda Pharmaceuticals Co	Fused heterocyclic derivatives and use thereof

2006
- 2006-11-30 TW TW095144339A patent/TW200730527A/zh unknown
- 2006-12-01 CA CA002631066A patent/CA2631066A1/fr not_active Abandoned
- 2006-12-01 PE PE2006001541A patent/PE20071089A1/es not_active Application Discontinuation
- 2006-12-01 US US12/095,543 patent/US20100216788A1/en not_active Abandoned
- 2006-12-01 AU AU2006319787A patent/AU2006319787A1/en not_active Abandoned
- 2006-12-01 WO PCT/JP2006/324499 patent/WO2007064045A1/fr not_active Ceased
- 2006-12-01 RU RU2008126949/04A patent/RU2008126949A/ru not_active Application Discontinuation
- 2006-12-01 AR ARP060105330A patent/AR057961A1/es unknown
- 2006-12-01 BR BRPI0619911A patent/BRPI0619911A2/pt not_active IP Right Cessation
- 2006-12-01 EP EP06834254A patent/EP1957495A1/fr not_active Withdrawn
- 2006-12-01 KR KR1020087016193A patent/KR20080084823A/ko not_active Withdrawn
- 2006-12-01 JP JP2008520459A patent/JP2009517333A/ja not_active Withdrawn
2008
- 2008-06-09 CR CR10057A patent/CR10057A/es not_active Application Discontinuation
- 2008-06-11 MA MA31024A patent/MA30046B1/fr unknown
- 2008-06-24 NO NO20082870A patent/NO20082870L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
US20100216788A1 (en)	2010-08-26
KR20080084823A (ko)	2008-09-19
AU2006319787A1 (en)	2007-06-07
CR10057A (es)	2008-07-29
CA2631066A1 (fr)	2007-06-07
BRPI0619911A2 (pt)	2016-08-30
EP1957495A1 (fr)	2008-08-20
WO2007064045A1 (fr)	2007-06-07
JP2009517333A (ja)	2009-04-30
RU2008126949A (ru)	2010-01-10
AR057961A1 (es)	2007-12-26
NO20082870L (no)	2008-09-01
TW200730527A (en)	2007-08-16
PE20071089A1 (es)	2007-11-19

Publication	Publication Date	Title
EP1873153A4 (fr)	2009-09-30	Compose heterocyclique
MA30046B1 (fr)	2008-12-01	Compose heterocyclique hybride
DK1919907T3 (da)	2011-04-18	Heterocyklisk forbindelse
EP2003132A4 (fr)	2010-05-12	Compose hetero
EP1732566A4 (fr)	2010-01-13	Compose de 6-azaindole
FR2889375B1 (fr)	2008-02-15	Structure resonnante hybride
BRPI0718266A2 (pt)	2014-01-07	Compostos heterocíclicos como agentes anti-inflamatórios.
EP1967403A4 (fr)	2008-12-31	Voiture hybride
EP2071162A4 (fr)	2010-10-06	Véhicule hybride
DK1931713T3 (da)	2013-03-11	Aryl-/alkylravsyreanhydridhyaluronderivater
DE602006015453D1 (de)	2010-08-26	Bleibatterie
CR10039A (es)	2008-07-10	Derivados espirocíclicos
EP1794507A4 (fr)	2011-05-11	Ventilateur hybride
DK1937650T3 (da)	2011-10-03	Heterocykliske forbindelser
NO20070299L (no)	2007-03-26	Novel heterocyclic compounds
DE602006010581D1 (de)	2009-12-31	4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate
FI20055630A0 (fi)	2005-11-30	Kasvonaamio
ATE485294T1 (de)	2010-11-15	Azaindol-2-carboxamid-derivate
ATE469058T1 (de)	2010-06-15	Zigarettenpackung
ATE527255T1 (de)	2011-10-15	Aryl-isoxazol-4-yl-imidazol-derivate
DK1971588T3 (da)	2012-10-22	Tiglien-3-onderivater
EP2004642A4 (fr)	2011-04-06	Agents chélatants polyazamacrocycliques bifonctionnels
FR2894580B1 (fr)	2014-04-11	Materiau hybride organique-inorganique mesostructure
ZA200800142B (en)	2009-05-27	Heterocyclic compound
DE502006006543D1 (de)	2010-05-12	Werkzeughalter